Breast cancer is a serious disease that plagues both men and women around the globe. US Breast Cancer statistics estimates that approximately one in eight women will develop invasive breast cancer at some time in their life. There are approximately 240,000 new cases of invasive breast cancer and 61,000 cases of noninvasive breast cancer diagnosed every year. There is no cure for breast cancer as of yet, though there is a significant amount of research focused upon it.
The Histopathology industry is one that requires exacting study techniques and can suffer exponentially when not having enough capital expenditure. Studying disease and doing pre-clinical research means you have to set a high bar for your reputation, which could easily shatter with one mistake.
The efficiencies that contract research organizations can gain from outsourcing preclinical histopathology services comes from a mix of organizational principles and industry specific standards. Of these, the three most critical success factors to consider are the quality of the slides and data, the speed and accuracy of completion, and price competitiveness.
In the role specimen storage plays in GLP preclinical studies, there is a simple answer; it is at the heart of pharmaceutical research and important to Food and Drug Administration approval for new drugs. However, that statement does need extensive qualification.
If you are exploring the resources available in support of preclinical histological testing, it is useful to understand how important archiving preclinical histology slides is in creating the context and environment in which it takes place.
Your Beginners Guide to Outsourcing Pathology Services should feature chapters on these three qualities: Efficiency, accuracy and affordability.
Do you really know how much capital expenditure you spend on your histopathology services? How about the amount of time you have to put in to manage your projects on a daily basis? If you're not paying attention, both are likely becoming challenging to control considering the complexity of the histology industry. With much of your time and resources going into studying the changes in tissues caused by disease, it's perhaps taking more money than you realize you're spending to keep projects moving forward. It's maybe at a point where you're realizing you've overstepped your boundaries on your budget, and time has become strained due to pressures of getting research done by strict deadlines.
Specimen Storage: Why FM-200 is the Best Fire Suppression System
The entire drug discovery process can be a long and arduous road; each step provides a crucial contribution to the final goal, which is safely and effectively treating patients with an FDA-approved drug. The preclinical phase relies significantly on high quality histotechnology, which comprises the cornerstone of safety and efficacy studies, therefore influencing all further phases of development for the test compound. The path to drug discovery includes the following:
513.204.4400
